I didn't actually count, but I was going to guess that there were probably about 20 shareholders, and we were matched, if not outnumbered, by company employees. My impression was that it was a bit smaller attendance by shareholders than in years past.
Our newest product, the GORE™ Protein Capture Device for small-scale affinity chromatography, uses the unique properties of a proprietary ePTFE composite combined with Protein A to fundamentally improve the purification process. Designed for drug discovery and screening applications, it provides significant capacity and speed improvements in the purification of monoclonal antibodies.